We wish to inform that the Board of Directors of the Company at its meeting held today, i.e., Friday, May 30, 2025, have approved the audited financial results for the quarter and financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Swasti Vinayaka Synthetics (BSE: 510245) announced audited financial results for Q4 FY25 and the full financial year ended March 31, 2025, approved at the board meeting held on May 30, 2025. For FY25, total income rose to Rs 38.56 crores from Rs 30.91 crores in FY24, a growth of about 25%. Net profit for FY25 increased to Rs 2.42 crores from Rs 1.98 crores in FY24, up roughly 23%. The statutory auditor, S P Jain & Associates, issued an unmodified (clean) opinion on the results. However, the company's net cash from operating activities remained negative at Rs -1.19 crores in FY25, and finance costs rose sharply from Rs 32.27 lacs to Rs 91.94 lacs.
Strong top-line growth and a clean audit opinion are positive signals, but the negative operating cash flow and a near-doubling of finance costs indicate rising working capital or debt servicing pressure that shareholders should monitor. The stock may see modest positive sentiment from the growth in revenue and profit, tempered by concerns over cash generation and leverage.